2-Carbon-Modified Analogs of 19-Nor-1α,25-Dihydroxyvitamin D3

Vitamin D

Volumn 2, Issue , 2005, Pages 1543-1555

  DeLuca, Hector F ^a   Plum, Lori A ^a   Clagett Dame, Margaret ^a   Shevde, Nirupama K ^a   Wesley Pike, J ^a   Sicinski, Rafal R ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646879383     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012252687-9/50091-7     Document Type: Chapter

References (33)

1. 3 compounds: Separation of calcium and cell differentiation activities. Biochemistry 1990, 29:190-196.
2. 3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 1987, 84:2610-2614.
3. Ostrem VK, Lau WF, Lee SH, Perlman K, Prahl J, Schnoes HK, DeLuca HF, Ikekawa N Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs. J Biol Chem 1987, 262:14164-14171.
4. Calverley MJ Synthesis of MC 903, a biologically active vitamin D metabolite. Tetrahedron 1987, 43:4609-4619.
5. 3 analogs. Chem Pharm Bull (Tokyo) 1992, 40:1494-1499.
6. Uskokovic MR, Baggiolini E, Shiuey SJ, Iacobelli J, Hennessy B, Kiegel J, Daniewski AR, Pizzolato G, Courtney LF, Horst RL The 16-ene analogs of 1,25-dihydroxycholecalciferol, synthesis, and biological activity. Vitamin D: Gene Regulation, Structurefunction Analysis and Clinical Application 1991, 139-145. De Gruyter, Berlin. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
7. Kragballe K Psoriasis and other skin diseases. Vitamin D 1997, 1213-1225. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
8. Binderup L, Kragballe K Origin of the use of calcipotriol in psoriasis treatment. Rev Contemp Pharmacother 1992, 3:401-409.
9. Jones G Analog metabolism. Vitamin D 1997, 973-994. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
10. Brown AJ, Ritter CS, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E The noncalcemic analog of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 1989, 84:728-732.
11. 3, a novel vitamin D-related compound with potential therapeutic activity. Tetraehedron Lett 1990, 31:1823-1824.
12. 3 compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series. Steroids 2002, 67:247-256.
13. 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis 1995, 26:852-860.
14. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R Survival of patients undergoing hemodialysis with paracalcitol or calcitriol therapy. N Engl J Med 2003, 349:446-456.
15. 3 isomers. Bioorg Chem 1994, 22:150-171.
16. Sicinski RR, DeLuca HF Synthesis of 6,7-diaza-19-nor-vitamin D compounds. Bioorg Med Chem Lett 1995, 4:899-904.
17. Calverley MJ, Binderup E, Binderup L The 20-epi modification in the vitamin D series: Selective enhancement of "non classical" receptor-mediated effects. Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical application 1991, 163-164. De Gruyter, Berlin, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
18. Hansen K, Calverley MJ, Binderup L Synthesis and biological activity of 22-oxa vitamin D analogs. Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Application 1991, 161-162. De Gruyter, Berlin, New York. A.W. Norman, R. Bouillon, M. Thomasset (Eds.).
19. Kubodera N, Sato K, Nishii Y: Characteristics of 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)-calcitriol (ED-71) In: D Feldman, FH Glorieux, JW Pike (eds) Vitamin D. Academic Press: San Diego, pp. 1071-1086.
20. 3. J Med Chem 1994, 37:3730-3738.
21. Brown AJ, Slatopolsky ES Mechanisms for the selective action of vitamin D analogs. Vitamin D 1997, 995-1009. Academic Press, San Diego. D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
22. Okamura WH, Norman AW, Wing RM Vitamin D: Concerning the relationship between molecular topology and biological function. Proc Natl Acad Sci USA 1974, 71:4194-4197.
23. 3 compounds of high biological activity: Synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs. J Med Chem 1998, 41:4662-4674.
24. 3 selectively induces bone formation. Proc Natl Acad Sci USA 2002, 99:13487-13491.
25. Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 1999, 140:1005-1008.
26. 3 with potent anabolic activity in bone. J Bone Min 2003, 18(Suppl. 2):S296-S302. (Abst).
27. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblast. J. Biol Chem 2003, 278:31756-31765.
28. 3 hormone analogs and an LxxLL-containing coactivator. Biochemistry 2004, 43:4101-4110.
29. Tocchini-Valentini G, Roche N, Wurtz JM, Mitschler A, Moras D Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 2001, 98:5491-5496.
30. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 1995, 270:10551-10558.
31. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
32. 3 stimulates dynamic vitamin D receptor/retinoid X receptor DNA binding and coactivator recruitment in intact osteoblasts. J Bone Min Res 2004, in press.
33. Kubodera N, Sato K, Nishii Y: Characteristics of 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)-calcitriol (ED-71) In: D Feldman, FH Glorieux, JW Pike (eds) Vitamin D. Academic Press: San Diego, pp. 1071-1086.